Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Lysophosphatidylcholine Stimulates IL-1β Release from Microglia via a P2X7 Receptor-Independent Mechanism

Christian Stock, Tom Schilling, Albrecht Schwab and Claudia Eder
J Immunol December 15, 2006, 177 (12) 8560-8568; DOI: https://doi.org/10.4049/jimmunol.177.12.8560
Christian Stock
*Institute of Physiology II, University of Muenster, Muenster, Germany, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Schilling
†Institute of Physiology, Medical Faculty Charité, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albrecht Schwab
*Institute of Physiology II, University of Muenster, Muenster, Germany, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Eder
†Institute of Physiology, Medical Faculty Charité, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

IL-1β released from activated macrophages contributes significantly to tissue damage in inflammatory, degenerative, and autoimmune diseases. In the present study, we identified a novel mechanism of IL-1β release from activated microglia (brain macrophages) that occurred independently of P2X7 ATP receptor activation. Stimulation of LPS-preactivated microglia with lysophosphatidylcholine (LPC) caused rapid processing and secretion of mature 17-kDa IL-1β. Neither LPC-induced IL-1β release nor LPC-stimulated intracellular Ca2+ increases were affected by inhibition of P2X7 ATP receptors with oxidized ATP. Microglial LPC-induced IL-1β release was suppressed in Ca2+-free medium or during inhibition of nonselective cation channels with Gd3+ or La3+. It was also attenuated when Ca2+-activated K+ channels were blocked with charybdotoxin (CTX). The electroneutral K+ ionophore nigericin did not reverse the suppressive effects of CTX on LPC-stimulated IL-1β release, demonstrating the importance of membrane hyperpolarization. Furthermore, LPC-stimulated caspase activity was unaffected by Ca2+-free medium or CTX, suggesting that secretion but not processing of IL-1β is Ca2+- and voltage-dependent. In summary, these data indicate that the activity of nonselective cation channels and Ca2+-activated K+ channels is required for optimal IL-1β release from LPC-stimulated microglia.

A wide variety of inflammatory diseases is closely linked to the activity of the proinflammatory cytokine IL-1β (1). In the CNS, IL-1β plays an important role in the pathogenesis of acute brain injury as well as chronic diseases (reviewed in Refs. 2 , 3). It is released after ischemic brain injury (4), seizure activity (5), mechanical injury (6), or infection or inflammation (7, 8). Elevated IL-1β levels have also been observed in the brain of patients with multiple sclerosis (9, 10), AIDS (11, 12), or Down’s syndrome and Alzheimer’s disease (13). IL-1β contributes significantly to brain damage. For example, IL-1β enhances neuronal injury caused by ischemic brain insults (14, 15). Brain damage can be reduced by IL-1R antagonist (16, 17).

Microglia are the major source of IL-1β in the brain (7). So far, little is known about agents inducing IL-1β release from microglia under pathological conditions. Using an animal model of prion disease Cunningham et al. (18) demonstrated recently that central and systemic inflammation evoked by LPS results in dramatic IL-1β expression by microglial cells. LPS also causes IL-1β release from cultured microglia in vitro (19, 20). Furthermore, rapid release of IL-1β from LPS-preactivated cultured microglial cells can be evoked by extracellular ATP (20, 21, 22, 23). ADP and AMP are capable of stimulating IL-1β release from microglial cells that were pretreated with ATP (24). All of these agents have been shown to induce IL-1β release from microglia by activating P2X7 ATP receptors (20, 21, 24, 25).

Lysophosphatidylcholine (LPC)4 is generated in the brain under pathological conditions that are accompanied by elevated IL-1β levels. Increased LPC concentrations of up to 200 μM were detected in the brain following ischemia (26, 27), epilepsy (28), and inflammation (29). Under pathological conditions, overstimulation of phospholipase A2 results in breakdown of membrane phosphatidylcholine and subsequent accumulation of LPC in the damaged tissue. LPC has also been shown to be secreted from apoptotic cells (30).

Little is known about effects of LPC in the brain and, in particular, on microglia. It has been demonstrated that microglial cells in vitro and in vivo transform from ramified into ameboid morphology following exposure to LPC (31, 32). Because activation of microglial cells in vitro and in vivo is accompanied by cell deramification (33, 34), it has been suggested that LPC leads to the activation of microglia (31, 32). This hypothesis is supported by the findings of the present study. We provide evidence that LPC stimulates processing and release of IL-1β from microglia and describe cellular mechanisms underlying the LPC-induced IL-1β release.

Materials and Methods

Primary and secondary microglial cell cultures

Microglia were obtained from brain cell cultures of newborn NMRI mice, supplied by Charles River Breeding Laboratories. Mixed brain cell cultures were prepared as previously described (32). After at least 10 days of incubation, microglia were harvested by shaking the cultures for 30 min at 300 rpm. Isolated microglia were seeded in 6-well plates at a density of 5 × 105/ml and maintained in DMEM supplemented with 10% FCS and 2 mM l-glutamine. Purity of microglial cell preparations was controlled by isolectin-B4 stainings (Molecular Probes). In all preparations, 98–100% of cells stained positive for this microglial/macrophage marker.

BV-2 microglial cells

BV-2 microglial cells were cultured permanently in DMEM supplemented with 10% FCS and 2 mM l-glutamine. BV-2 cells were split twice a week, and were plated on glass coverslips at a density of 1 × 105/ml for subsequent patch-clamp and Ca2+ imaging experiments. For ELISA and caspase activity measurements, BV-2 cells were cultured in 6-well plates or 35-mm petri dishes at a density of 5 × 105/ml.

Chemicals

The drugs used in this study were: LPS; synthetic l-α-LPC, palmitoyl (16:0); LPC, stearoyl (18:0); LPC, oleoyl (18:1); GdCl3; LaCl3; nigericin; valinomycin; BzATP (2′,3′-O-(4-benzoylbenzoyl)5′ATP); oxidized ATP (oATP); charybdotoxin (CTX; Latoxan); margatoxin (MTX; Peptide Institute); YVAD-CHO (Ac-Tyr-Val-Ala-Asp-aldehyde Bachem); and recombinant murine IL-1β (R&D Systems). If not stated otherwise, drugs were obtained from Sigma-Aldrich. YVAD-CHO was dissolved in DMSO and a 100 mM stock solution was prepared. Nigericin and valinomycin were dissolved in ethanol and stored as 20 and 10 mM stock solutions, respectively. All other drugs were dissolved in extracellular solution.

Solutions

Extracellular solution E1 contained 130 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM d-glucose (pH 7.4). In some experiments CaCl2 was omitted from the extracellular solution, while 1 mM EGTA was added and the concentration of MgCl2 was increased to 4 mM (which became the Ca2+-free extracellular solution E2). The extracellular solution E3 contained 140 mM NaCl, 2 mM MgCl2, and 10 mM HEPES (pH 7.4). Intracellular solution I1 contained 125 mM CsCH3SO3, 2 mM MgCl2, 10 mM HEPES, and 1 mM BAPTA (pH 7.3). Intracellular solution I2 contained 120 mM KCl, 2 mM MgCl2, 10 mM HEPES, and 0.1 mM BAPTA (pH 7.3).

Detection of IL-1β by ELISA

In most cases, primary cultured and BV-2 microglial cells were preincubated with 1 μg/ml LPS in DMEM/FCS culture medium at 37°C for 6 h. Immediately before the experiments, cells were washed twice with extracellular solution E1. Thereafter, cells were treated with 1 ml of DMEM, Ca2+-containing extracellular solution E1 or Ca2+-free extracellular solution E2 in the absence or presence of LPC and inhibitors. After incubation of cells for 1 h at 37°C, supernatants were collected and the concentration of IL-1β was determined. Data were obtained from at least three individual microglia cultures in two to four different wells per experimental condition. For the quantitative determination of IL-1β concentration in microglial cell culture supernatants, Quantikine mouse IL-1β Immunoassay kit (R&D Systems) was used according to the manufacturer’s instructions. The sensitivity of this sandwich ELISA was <3 pg/ml.

Detection of IL-1β by immunoblot analysis

LPS-preactivated primary cultured microglial cells were washed twice with extracellular solution E1 immediately before experiments. After a subsequent exposure for 1 h to 1 ml of extracellular solution E1 in the presence or absence of LPC and inhibitors, cell lysates or supernatants were collected and IL-1β contents were determined by immunoblot analysis. Cell supernatants were concentrated using Microcon centrifugal filters (Millipore) with a 3-kDa cutoff. Cells were lysed with 1% Triton X-100 in the presence of a protease inhibitor mix (Complete Mini; Roche). Protein quantification was performed colorimetrically using Pierce bicinchoninic acid protein assay. The amount of total protein was determined according to the manufacturer’s protocol (Pierce). Normalized amounts of cell supernatants or lysates were run on a 10% SDS-polyacrylamide gel and then transferred onto nitrocellulose membranes (Schleicher & Schuell). To reduce nonspecific Ab binding, membranes were bathed in 5% (w/v) low-fat milk in 0.1% (v/v) Tween 20 in PBS for 1 h at room temperature and then washed with 0.1% Tween 20 in PBS. Thereafter, membranes were probed with a polyclonal goat anti-mouse IL-1β Ab (R&D Systems) at 1/250 dilution and were incubated overnight at 4°C, followed by a 1 h incubation with a HRP-conjugated polyclonal donkey anti-goat IgG (1/7500; R&D Systems) at room temperature. Immunoblots were developed using an ECL immunoblotting detection reagent kit (Pierce Supersignal West Femto, Perbio Science). Ab dilutions were prepared in 5% (w/v) low-fat milk in 0.1% Tween 20 in PBS. Quantitative analysis of background-corrected pro-IL-1β and IL-1β band densities was performed using the image processing software analySIS (Olympus Optical).

Detection of IL-1-converting enzyme (ICE)/caspase-1 activity

Activity of ICE/caspase-1 was revealed by FITC-VAD-FMK in situ (Promega) as previously described (35). Microglial cells were incubated with 10 μM FITC-VAD-FMK in extracellular solution during the 1 h of LPC stimulation. Cells were bathed in extracellular solutions E1 or E2. After LPC stimulation, cells were washed twice with extracellular solution and then fixed for 10 min with a fixative containing 4% paraformaldehyde, 15% of a saturated solution of picric acid and 0.1% glutaraldehyde in phosphate buffer (pH 7.4). Fluorescence intensity of cells was analyzed using an upright microscope BX51Wi (Olympus Optical) and the image processing software analySIS (Olympus Optical). The fluorescence imaging system consisted of a mercury lamp, a charge-coupled device camera (F-View II, Olympus Optical), an excitation filter of 470–490 nm wavelength, a dichroic mirror of 505 nm wavelength, and a barrier filter of 510–550 nm wavelength (all from Olympus Optical). Images of four different visual fields for three independent experiments per condition were collected and analyzed. Fluorescence intensities of all cells were corrected for background fluorescence.

Cell viability test

The influence of LPC on membrane integrity was investigated using ethidium bromide (Molecular Probes) staining as previously described (36). Cells were treated with or without 30 μM LPC and incubated in extracellular solution E1 at 37°C for 1 h. Then, cells were washed and incubated with extracellular solution E1 containing 10 μM ethidium bromide for 10 min. After washing, petri dishes were mounted on an Olympus IX 50 microscope and cells were excited with monochromatic light at a wavelength of 530 nm. Images of four different visual fields for five independent experiments per condition were collected. As a positive control for ethidium bromide staining cells were damaged by freezing and subsequent thawing.

Electrophysiological recordings

Whole cell membrane currents and membrane potentials were measured using an EPC-9 Patch Clamp Amplifier (HEKA Electronics). The amplifier was interfaced to an IBM computer for pulse application and data recording. Series resistance compensation was routinely used to reduce the effective series resistance by ∼70%. Patch electrodes of 2–4 MOhms were fabricated on a two-stage Narishige PP-83 puller from borosilicate glass (outer diameter at 1.5 mm and inner diameter at 1 mm; Hilgenberg). Solutions I1 and E3 were used for measurements of nonselective cation currents, while solutions I2 and E1 were used for measurements of Ca2+-activated K+ currents and of membrane potentials. All recordings were done at room temperature (20–23°C). Whole cell currents were filtered at 3 kHz and stored on computer disk for subsequent analyses. Analyses were performed on IBM computers with the Pulse/PulseFit program (HEKA Electronics). Data were corrected for liquid junction potentials. Data are presented as mean ± SEM. The number of experiments is indicated.

Ca2+ imaging

Microglial cells were loaded with 3 μM fura 2-AM (Molecular Probes) in extracellular solution for 30 min at room temperature (20–23°C). After washing, coverslips were mounted in a chamber on an inverted Olympus IX 50 microscope equipped with a water immersion objective ×40 UApo/340. The fluorescence imaging system consisted of a monochromator, a CCD camera and the Windows NT based image processing software (Till Photonics). Microglial cells were exposed to alternating 340 ± 5 nm and 380 ± 5 nm wavelengths of UV light and emission light was passed through a 400 nm dichroic mirror and a 420 nm long pass emission filter (both Olympus Optical) before acquisition by the CCD camera. Images were collected every 20 s. In some experiments images were collected every 5 s. The ratio of the two background corrected fluorescence intensities was converted to the intracellular Ca2+ concentration ([Ca2+]i) of a single cell according to the equation of Grynkiewicz et al. (37): [Ca2+]i = Kdβ (R−Rmin)/(Rmax−R), where Kd = 224 nM is the dissociation constant of fura and R is the measured ratio. Rmin (0.375) and Rmax (3.930) were determined using 10 μM ionomycin in extracellular solution containing zero Ca2+ (using 2 mM EGTA) or 10 mM Ca2+, respectively, and β (5.66) was calculated as the ratio of the fluorescence intensities at 380 nm in 0 and 10 mM Ca2+. The extracellular solution E1 was used for Ca2+ imaging experiments. Some experiments were performed using Ca2+-free extracellular solution E2.

Statistics

The statistical significance of differences between experimental groups was evaluated by the Mann-Whitney U test using the SPSS program. Data were considered to be statistically significant with p < 0.05.

Results

LPC-induced release of IL-1β from microglial cells

To determine whether LPC (palmitoyl 16:0) is capable of inducing IL-1β release, microglial cells were stimulated for 1 h with LPC. Before LPC application, microglial cells were treated with 1 μg/ml LPS for 6 h. Without LPS activation IL-1β was undetectable in supernatants of unstimulated cells or of LPC-stimulated cells (n = 3 experiments in each case). In agreement with previous observations (38), levels of IL-1β released by cells maintained either in bicarbonate-buffered cell culture medium DMEM or in HEPES-buffered extracellular solution E1 were comparable (n = 5 experiments). Therefore, if not stated otherwise, cells were maintained in extracellular solution E1 during the time of LPC stimulation in all subsequent experiments. Both primary cultured microglial cells and BV-2 microglial cells released substantial amounts of IL-1β following stimulation with LPC. Although the total amount of IL-1β was larger in supernatants of primary microglial cells than in supernatants of BV-2 cells, the relative increases in IL-1β produced by LPC-stimulated primary cultured microglia and BV-2 microglial cells were comparable. After stimulation with 15 μM LPC, levels of IL-1β increased 9.5-fold in primary microglia (untreated, 101 ± 41 pg/ml; 15 μM LPC, 959 ± 140 pg/ml; n = 6 experiments) and 8-fold in BV-2 cells (untreated, 2.6 ± 0.6 pg/ml; 15 μM LPC, 21.1 ± 2.0 pg/ml; n = 11 experiments). Upon treatment with 30 μM LPC, the increase in IL-1β production was 17-fold in primary microglia (untreated, 101 ± 41 pg/ml; 30 μM LPC, 1746 ± 215 pg/ml; n = 3 experiments) and 25-fold in BV-2 cells (untreated, 2.3 ± 0.6 pg/ml; 30 μM LPC, 58.2 ± 6.1 pg/ml; n = 16 experiments) (Fig. 1⇓A). Similar to observations made on monocytes (39), monounsaturated LPC (oleoyl 18:1; 15 μM) did not lead to substantial IL-1β release (119 ± 21 pg/ml; n = 3 experiments) from primary microglial cells. The amount of IL-1β released from primary microglia stimulated with 15 μM LPC (stearoyl 18:0, 985 ± 247 pg/ml; n = 3 experiments) did not differ significantly from that released from microglia stimulated with 15 μM LPC (palmitoyl 16:0, 959 ± 140 pg/ml; n = 6 experiments). LPC (palmitoyl 16:0) was used in all subsequent experiments.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

LPC-induced IL-1β release from microglial cells. A, Relative increases in IL-1β production from primary microglial cells (▪) and BV-2 microglial cells (□) stimulated with 15 or 30 μM LPC for 1 h. B, Time course of LPC-stimulated IL-1β release from microglia. BV-2 microglial cells were stimulated with 30 μM LPC (▪) or 45 μM (○) LPC for different times as indicated. Concentrations of IL-1β were normalized to the amounts of IL-1β released after LPC stimulation for 1 h. A and B, Before stimulation with LPC, all microglial cells were pretreated with 1 μg/ml LPS for 6 h in DMEM/FCS culture medium. During LPC stimulation, all cells were maintained in extracellular solution E1. IL-1β levels (mean ± SEM) of cell supernatants were determined by ELISA.

To test whether LPC has toxic effects on microglial cells, we performed ethidium bromide stainings of microglial cells incubated for 1 h in the presence or absence of 30 μM LPC. Ethidium bromide staining was detected in 1.6 ± 0.6% (n = 5 experiments) of untreated control cells and in 4.9 ± 1.1% (n = 5 experiments) of LPC-treated microglial cells. These data suggest that LPC did not cause significant damage to microglial cells.

Fig. 1⇑B demonstrates the time-dependence of IL-1β release from LPC-stimulated microglial cells. Within the first 10–15 min of LPC stimulation, microglial cells released ∼50% of the amount of IL-1β measured after 1 h of LPC treatment. The levels of IL-1β determined for cells exposed to LPC for 45 or 60 min did not differ significantly.

Next, it was clarified whether mature IL-1β or pro-IL-1β is released from microglia following LPC stimulation. In these experiments, BV-2 microglial cells were preincubated for 1 h with 100 μM YVAD-CHO, which prevents maturation of pro-IL-1β by inhibiting ICE/caspase-1. In the presence of YVAD-CHO, IL-1β release was inhibited by 84% in cells stimulated with 15 μM LPC and by 61% in cells treated with 30 μM LPC (n = 4 experiments for each LPC concentration) (Fig. 2⇓A). These data suggest that the majority of IL-1β released from LPC-stimulated microglia is in the mature active form. Immunoblot analysis revealed the presence of the fully processed and biologically active 17-kDa IL-1β in supernatants of LPC-stimulated primary cultured microglia. Release of the 17-kDa mature IL-1β was markedly reduced upon preincubation of microglial cells with 100 μM YVAD-CHO (n = 12) (Fig. 2⇓, B1 and B2). In some experiments, small amounts of the premature and biologically inactive 33-kDa pro-IL-1β were detected in addition to the 17-kDa IL-1β (Fig. 2⇓B2). Release of pro-IL-1β was not inhibited following pretreatment of microglial cells with YVAD-CHO. The amount of extracellular pro-IL-1β of microglial cells preincubated with YVAD-CHO was 104% (n = 3 experiments) of that determined for cells kept in the absence of YVAD-CHO, while mature IL-1β was reduced to 17% in these YVAD-CHO-treated cells.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

LPC-induced release of mature IL-1β from microglia. Before LPC stimulation, some cells were preincubated with 100 μM YVAD-CHO for 1 h in LPS-containing DMEM/FCS culture medium. Following the YVAD-CHO pretreatment, microglial cells were stimulated with 15 μM (▪) or 30 μM (□) LPC for 1 h in solution E1. A, Effects of YVAD-CHO on LPC-induced IL-1β release from BV-2 microglia were assayed by ELISA (∗, p < 0.05; ∗∗, p < 0.01 vs LPC). B, Western blot analyses of IL-1β released from primary cultured microglial cells. The majority of LPC-stimulated cells released exclusively mature 17-kDa IL-1β (B1), which was substantially reduced upon inhibition of the ICE/caspase-1 with YVAD-CHO. Some LPC-stimulated microglial cells released both 33-kDa pro-IL-1β and 17-kDa mature IL-1β (B2). Release of pro-IL-1β was not inhibited by YVAD-CHO.

It has been demonstrated before that signaling pathways involved in IL-1β processing and release (40) as well as ion channel expression (32, 41) are similar in BV-2 microglial cells and in primary cultured microglial cells. Therefore, if not stated otherwise, BV-2 microglial cells were used in all subsequent experiments.

LPC-induced release of IL-1β from microglial cells is independent of P2X7 receptor activation

Performing Ca2+ imaging and ELISA experiments, it was tested whether LPC mediates its effects by P2X7 receptor activation. All experiments were performed on activated microglial cells that had been pretreated with 1 μg/ml LPS for 6 h. Application of 100 μM BzATP, a P2X7 receptor agonist, caused sustained increases in [Ca2+]i of microglial cells (Fig. 3⇓A). In the presence of BzATP, [Ca2+]i increased from a resting level of 74 ± 2 nM to 2624 ± 124 nM (n = 123 cells). After the initial Ca2+ peak, [Ca2+]i remained increased reaching a plateau at 732 ± 21 nM (n = 123 cells). To inhibit P2X7 receptors, microglial cells were pretreated with 500 μM oATP for 4 h. Following pretreatment with oATP, microglial cells had a mean resting [Ca2+]i of 70 ± 2 nM (n = 103 cells), which was not significantly different from that of untreated cells. In oATP-pretreated cells, 100 μM BzATP induced only small transient Ca2+ increases but failed to induce sustained Ca2+ increases (Fig. 3⇓B). The lack of sustained Ca2+ increases indicates complete inhibition of microglial P2X7 receptors by oATP. The remaining small Ca2+ transients reflect BzATP-induced activation of other ATP receptor types.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

No effect of oATP on LPC-induced Ca2+ signals. Measurements of [Ca2+]i were performed in fura 2-AM-loaded microglial cells. A, Effects of 100 μM BzATP on [Ca2+]i of untreated microglial cells. B, Effects of 100 μM BzATP on [Ca2+]i of cells pretreated with 500 μM oATP for 4 h in LPS-containing DMEM/FCS culture medium. C, Effects of 15 μM LPC on [Ca2+]i of untreated microglial cells. D, Pretreatment of microglial cells with 500 μM oATP did not change LPC-induced Ca2+ signals. Representative Ca2+ signals of individual cells are n = 32 cells (A), n = 25 cells (B), n = 17 cells (C), and n = 15 cells (D).

In additional experiments, effects of LPC on microglial cells were investigated following P2X7 receptor inhibition. No significant differences were found between LPC-induced Ca2+ responses of untreated (Fig. 3⇑C) and oATP-pretreated (Fig. 3⇑D) microglial cells. Under both conditions, LPC caused sustained Ca2+ increases consisting of an initial peak and a subsequent plateau phase. None of the determined mean values of [Ca2+]i before or during application of LPC differed markedly between untreated and oATP-pretreated microglial cells. Following application of 15 μM LPC, [Ca2+]i of untreated cells (n = 158 cells) increased from 95 ± 2 nM to 2302 ± 104 nM and reached a plateau of 812 ± 16 nM. In oATP-pretreated microglial cells (n = 144 cells), resting [Ca2+]i was 101 ± 2 nM, while mean values of 2182 ± 162 nM and 745 ± 23 nM were determined for LPC-induced [Ca2+]i peak and plateau, respectively.

Next, we investigated whether in microglia LPC-induced IL-1β release is influenced by P2X7 receptor inhibition with oATP. As demonstrated in Fig. 4⇓, LPC-induced IL-1β release from microglial cells was unaffected by oATP. Untreated control cells and cells pretreated with 500 μM oATP for 4 h released almost identical amounts of IL-1β following stimulation with LPC (n = 3 experiments).

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

No effect of oATP on LPC-induced IL-1β release. Some microglial cells were pretreated with 500 μM oATP for 4 h in LPS-containing DMEM/FCS culture medium. IL-1β release was determined by ELISA. Inhibition of P2X7 receptors with oATP did not affect LPC-induced IL-1β release from microglia.

Ca2+ dependence of LPC-induced release of IL-1β from microglia

The LPC-induced sustained increases in [Ca2+]i (Fig. 5⇓A) were exclusively caused by Ca2+ influx from the extracellular space. Increases in [Ca2+]i could not be elicited by LPC when cells were maintained in Ca2+-free extracellular solution E2 (Fig. 5⇓B). As demonstrated in Fig. 5⇓C, increases in [Ca2+]i are important for LPC-induced IL-1β release from microglia. LPC-stimulated microglial cells released less IL-1β in the absence of extracellular Ca2+ than in the presence of extracellular Ca2+. In Ca2+-free extracellular solution E2, IL-1β release of cells stimulated with 15 μM LPC was reduced by 80% (n = 4 experiments) compared with the levels of IL-1β released in Ca2+-containing extracellular solution E1. In microglial cells stimulated with 30 μM LPC, IL-1β release was reduced by 77% (n = 4 experiments) after omission of extracellular Ca2+ (Fig. 5⇓C).

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Effects of Ca2+-free extracellular solution on LPC-induced Ca2+ signals and IL-1β release. Measurements of [Ca2+]i were performed in fura 2-AM-loaded microglial cells. A, LPC (15 μM) caused sustained increases in [Ca2+]i. Representative Ca2+ signals of individual cells (n = 16 cells) are shown. B, Lack of Ca2+ elevation in Ca2+-free extracellular solution E2. Representative Ca2+ signals of individual cells (n = 14 cells) are shown. C, Effects of Ca2+-free extracellular solution on IL-1β release from LPC-stimulated cells. Released IL-1β was determined by ELISA. Cells were stimulated with 30 μM LPC in the presence of extracellular solution E1 containing 2 mM Ca2+ or in the presence of Ca2+-free extracellular solution E2. In Ca2+-free extracellular solution E2 (0 [Ca2+]o), IL-1β release from microglia was significantly inhibited. ∗∗∗, p < 0.001 vs LPC.

Importance of nonselective cation channels for LPC-induced IL-1β release from microglia

Patch-clamp experiments were performed to identify the LPC-induced Ca2+ influx pathway. Application of LPC elicited nonselective cation currents in LPS-pretreated microglial cells as shown in Fig. 6⇓. Biophysical and pharmacological properties of LPC-induced nonselective cation currents of microglia have been characterized in detail elsewhere (32). Pretreatment of microglial cells with LPS did not change properties of nonselective cation currents. In microglial cells, the most effective inhibitors of LPC-induced nonselective cation currents are Gd3+ (Fig. 6⇓A) and La3+ (Fig. 6⇓B). Both lanthanides abolish microglial nonselective cation currents at a concentration of 100 μM (n = 19 cells for Gd3+; n = 10 cells for La3+). Effects of lanthanides on LPC-induced IL-1β release from microglial cells are demonstrated in Fig. 6⇓C. In the presence of either 100 μM Gd3+ or 100 μM La3+, IL-1β release from microglial cells stimulated with 15 or 30 μM LPC was completely inhibited (n = 4 experiments for each condition).

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Nonselective cation channel pharmacology and importance for LPC-induced IL-1β release. A and B, Currents were measured in the whole cell configuration of the patch-clamp technique. Cells were held at 0 mV, and voltage ramps were applied from −90 to +60 mV for a duration of 300 ms every 10 s. Nonselective cation currents were evoked by 15 μM LPC and measured using intracellular solution I1 and extracellular solution E3. LPC-induced currents were recorded in the absence (LPC) and presence of 100 μM Gd3+ (LPC+Gd3+) in A or 100 μM La3+ (LPC+La3+) in B. C, Effect of Gd3+ and La3+ on LPC-stimulated IL-1β release. Released IL-1β was determined by ELISA. IL-1β release from microglia was abolished by inhibition of nonselective cation channels with either Gd3+ or La3+ (∗∗∗, p < 0.001 vs LPC).

Importance of Ca2+-activated K+ channels for LPC-induced IL-1β release from microglia

LPC-induced sustained increases in [Ca2+]i caused the activation of Ca2+-dependent K+ channels in LPS-pretreated microglial cells. Ca2+-dependent K+ currents of LPS-pretreated microglia were similar to those of unstimulated microglia described before (32, 42, 43). As shown in Fig. 7⇓A, in the presence of 200 nM CTX, LPC-activated Ca2+-dependent K+ currents were abolished, whereas nonselective cation currents remained unaffected. Under control conditions before LPC stimulation, the mean resting membrane potential of microglial cells was −50.1 ± 5.2 mV (n = 7 cells). Microglial resting membrane potential was unaffected by CTX (n = 6 cells). Upon activation of Ca2+-dependent K+ channels, LPC-stimulated microglial cells reached hyperpolarized membrane potentials of −70 ± 1.6 mV (n = 7 cells). Inhibition of the channels with CTX caused membrane depolarization. In the presence of 200 nM CTX, LPC-stimulated microglial cells depolarized on average to −22.7 ± 2.3 mV (n = 7 cells) (Fig. 7⇓B). Upon LPS pretreatment, microglial cells up-regulated the expression of voltage-activated K+ channels, which are also CTX-sensitive. Therefore, we studied additionally effects of 1 nM MTX, which inhibits voltage-activated K+ channels but not Ca2+-activated K+ channels in microglia. In contrast to CTX, MTX failed to inhibit LPC-induced membrane hyperpolarization (n = 4 cells), suggesting that membrane hyperpolarization was exclusively caused by the activity of Ca2+-activated K+ channels.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

LPC-induced activation of Ca2+-activated K+ channels. A, Currents (I) were measured in the whole cell configuration of the patch-clamp technique. Microglial cells were held at −60 mV. Voltage (V) ramps were applied from −120 to +30 mV for a duration of 300 ms every 20 s. LPC-induced Ca2+-activated K+ currents were recorded before (LPC) and during application of 200 nM CTX (LPC+CTX). B, Membrane potential (mean ± SEM) of LPC-stimulated microglial cells was determined in current clamp measurements of the patch-clamp technique in the absence (−) and presence (+) of 200 nM CTX. All values were significantly different from each other (p < 0.01). Horizontal bars are mean values of membrane potentials; error bars are SEM of the corresponding mean values. Measurements in each experiment were performed using intracellular solution I2 and extracellular solution E1.

The inhibitory effect of 200 nM CTX on LPC-induced IL-1β release is demonstrated in Fig. 8⇓A. In the presence of CTX, microglial cells released only 26% or 39.5% of the amount of IL-1β determined in the absence of CTX after stimulation with 15 μM (n = 3 experiments) or 30 μM (n = 4 experiments) LPC, respectively. These data determined by ELISA were supported by densitometric analysis of Western blots. Release of mature IL-1β from primary microglia stimulated with 15 μM LPC was reduced to 33.6% by 200 nM CTX (n = 3 experiments). The small bands of pro-IL-1β of LPC-stimulated cells (seen in two of three experiments) were undetectable in CTX-treated cells, suggesting that CTX inhibits release of both pro-IL-1β and mature IL-1β. Inhibition of voltage-gated K+ channels with 1 nM MTX did not affect LPC-induced IL-1β release (n = 3 experiments) (Fig. 8⇓B).

FIGURE 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 8.

Importance of Ca2+-activated K+ channels for LPC- induced IL-1β release. A–C, Effects of K+ channel inhibitors on LPC-induced IL-1β release from microglia. Released IL-1β was determined by ELISA. A, Inhibition of LPC-stimulated IL-1β release by 200 nM CTX (∗, p < 0.05 vs LPC). B, Lack of effect of 1 nM MTX on LPC-stimulated IL-1β release. C, Inhibitory effects of CTX on IL-1β release from LPC-stimulated microglial cells was not reversed by 10 μM nigericin (nig.). ∗, p < 0.05 vs LPC plus nigericin.

Additional experiments were performed to test whether the CTX-induced inhibition of LPC-induced IL-1β release was due to membrane depolarization or due to inhibition of K+ efflux. We investigated effects of CTX on LPC-induced IL-1β release in the presence of 10 μM nigericin, which allowed K+ efflux, while the CTX-induced membrane depolarization remained stable. As demonstrated in Fig. 8⇑C, the K+ ionophore nigericin was unable to reverse CTX-induced inhibition of IL-1β release from LPC-stimulated microglial cells. Nigericin alone (10 μM) did not cause significant increases in IL-1β release from microglial cells. In its presence, LPC-stimulated IL-1β release was inhibited by CTX by 60 ± 13% (n = 3 experiments) (Fig. 8⇑C), which was almost identical with the inhibitory effect of CTX on LPC-stimulated IL-1β release (60.4 ± 16%; n = 4 experiments) (Fig. 8⇑A) determined in the absence of nigericin. These data suggest that a hyperpolarized membrane potential is required for optimal IL-1β release from LPC-stimulated microglial cells.

In additional experiments, membrane hyperpolarization was induced by 1 μM valinomycin. In the presence of valinomycin, CTX failed to inhibit the LPC-induced IL-1β release. CTX-treated microglial cells released 108% (n = 3 experiments) of the amount of IL-1β released from cells in the absence of CTX. Thus, it can be excluded that CTX has unspecific effects that are unrelated to K+ channel inhibition.

No importance of K+/Cl− cotransporters for LPC-induced IL-1β release from microglia

We have demonstrated previously that K+/Cl− cotransporters are involved in LPC-induced shape changes of microglial cells (32). Therefore, it was tested whether activity of K+/Cl− cotransporters is also required for optimal IL-1β release from microglial cells. In these experiments, levels of IL-1β were determined in supernatants of cells stimulated with LPC in the presence or absence of 1 mM furosemide. Inhibition of K+/Cl− cotransporters with furosemide did not affect LPC-induced IL-1β release. Following stimulation with 30 μM LPC, levels of IL-1β released from furosemide-treated microglial cells were 105.8 ± 23% (n = 4 experiments) of those released from cells in the absence of furosemide.

LPC-induced changes in caspase activity

In a final set of experiments, it was clarified whether Ca2+-free extracellular solution and CTX affect either processing or release of IL-1β. To investigate LPC-induced processing of pro-IL-1β to the mature IL-1β, caspase activity was determined in situ by the fluorogenic substrate FITC-VAD-FMK, which binds exclusively active caspases. As shown in Fig. 9⇓, the mean fluorescence intensity of FITC-VAD-FMK-loaded microglial cells was increased 4-fold following stimulation with 30 μM LPC (untreated, n = 1054 cells; LPC-treated, n = 1034 cells). Neither omission of Ca2+ from the extracellular medium nor CTX inhibited caspase activity of LPC-stimulated microglial cells. The mean fluorescence intensity of LPC-stimulated microglial cells maintained in Ca2+-containing solution E1 did not differ markedly from that of LPC-stimulated cells kept in Ca2+-free extracellular solution E2 (n = 765 cells). Furthermore, the mean fluorescence intensities of cells stimulated for 1 h with LPC in the absence (n = 1034 cells) or presence of 200 nM CTX (n = 1000 cells) were almost identical. Western blot analyses of intracellular pro-IL-1β did also not reveal significant differences between cells maintained in the absence or presence of 200 nM CTX. On average, the amount of intracellular pro-IL-1β of microglial cells stimulated with LPC in the presence of CTX was 114.4±15% (n = 3 experiments) of that determined in the absence of CTX. These data suggest that the LPC-induced processing of IL-1β in microglial cells was neither Ca2+- nor voltage-dependent.

FIGURE 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 9.

Caspase activity of LPC-stimulated microglial cells. A–D, All cells were pretreated with 1 μg/ml LPS for 6 h in DMEM/FCS culture medium. Subsequently, cells were maintained in Ca2+-containing extracellular solution E1 (A, B, and D) or in Ca2+-free extracellular solution E2 (C) at 37°C for 1 h. Microglial cells were kept untreated (A) or were stimulated (B) with 30 μM LPC in the absence or presence of 200 nM CTX (D) or in Ca2+-free extracellular solution E2 (C). Brightfield microscopy images (left column) and fluorescence images (right column) are shown. E, Relative fluorescence intensities (mean ± SEM) of FITC-VAD-FMK-loaded untreated and LPC-treated microglial cells are quantitated. Neither Ca2+-free solution nor CTX affected caspase activity of LPC-stimulated microglia.

Discussion

LPC-induced release of IL-1β from microglia

In the present study, we provide the first evidence that LPC is capable of inducing rapid release of IL-1β from microglial cells. Furthermore, this study is the first demonstrating a novel ATP-receptor-independent mechanism of IL-1β release from microglia.

Upon stimulation with LPC, release of IL-1β occurs rapidly from microglial cells preactivated with LPS. Microglial IL-1β was undetectable in microglial cultures without LPS pretreatment. This finding is in good agreement with previous observations on ATP-stimulated microglial cells (20, 22). LPS is required for up-regulating the synthesis of pro-IL-1β and the expression of ICE/caspase-1 (44). Processing of pro-IL-1β to IL-1β requires cleavage by the enzyme ICE/caspase-1 (45). We further demonstrate that the majority of IL-1β released from microglial cells following LPC stimulation is in the mature, active 17-kDa form. Thus, similar to extracellular ATP, LPC induces both processing and secretion of IL-1β.

Activation of P2X7 ATP receptors has been proposed to be a prerequisite for the release of IL-1β from microglial cells. Previous studies have shown that IL-1β release from microglia stimulated with ATP (20, 22), LPS (19, 20), ADP or AMP (24) is mediated by P2X7 receptor activation. In contrast, we found that specific inhibition of microglial P2X7 receptors with oATP (46) prevented neither LPC-stimulated Ca2+ signals nor LPC-induced IL-1β release. These data indicate that LPC induces IL-1β release from microglia by a mechanism independent of P2X7 receptor activation.

Ca2+ dependence of LPC-induced IL-1β release from microglia

Several studies on peripheral tissue macrophages have shown that the ATP-triggered IL-1β release is a Ca2+-dependent process. However, controversial data exist regarding the mechanism leading to enhanced intracellular Ca2+ concentrations sufficient to induce IL-1β release. Ca2+ influx from the extracellular space through P2X7 receptor-coupled nonselective cation channels (47, 48) or Ca2+ release from intracellular stores (49) have been suggested to initiate IL-1β release from ATP-stimulated macrophages. Similar to the ATP-induced IL-1β release from peripheral tissue macrophages, LPC-stimulated IL-1β release from microglia is Ca2+-dependent. It was inhibited following omission of extracellular Ca2+ or during blockade of nonselective cation channels. Thus, sustained Ca2+ entry from the extracellular space mediated by the activity of nonselective cation channels is required for LPC-induced microglial IL-1β release. In microglia, LPC causes exclusively Ca2+ influx through nonselective cation channels, but fails to evoke Ca2+ release from intracellular stores (Ref. 32 and the present study). Thus, it can be excluded that Ca2+ release from intracellular stores is a prerequisite for LPC-induced IL-1β release from microglia. LPC-induced sustained increases in [Ca2+]i have also been described in human monocytes (50).

Voltage-dependence of LPC-induced IL-1β release from microglia

Microglial LPC-stimulated IL-1β release was attenuated in the presence of CTX but was unaffected by MTX. These data indicate that Ca2+-activated K+ channels but not voltage-activated K+ channels are important for LPC-stimulated IL-1β release. Similar to our observations, ATP-stimulated IL-1β release from peripheral tissue macrophages is independent of voltage-activated K+ channel activity (51). The reduction of IL-1β levels released from LPC-stimulated microglia during inhibition of Ca2+-activated K+ channels with CTX could be explained by inhibition of either IL-1β processing or IL-1β secretion. Our observation that LPC-stimulated activity of ICE/caspase-1 remained unchanged in the presence of CTX suggests that CTX inhibits secretion of IL-1β rather than the transformation process of pro-IL-1β into mature IL-1β.

What is the functional importance of Ca2+-activated K+ channels for LPC-stimulated microglial IL-1β release? Activity of Ca2+-activated K+ channels is required to keep the membrane potential of cells at negative, i.e., hyperpolarized, values. We suggest that membrane hyperpolarization is required for optimal IL-1β release and that the CTX-induced inhibition of LPC-stimulated IL-1β release is due to membrane depolarization. Our results on the inhibitory effect of CTX on LPC-stimulated IL-1β release are in line with previous studies demonstrating that high K+-containing solution, which also causes membrane depolarization, inhibits IL-1β release from ATP-stimulated microglia (22). However, CTX and high K+-containing extracellular solution also lead to reduced K+ efflux, which seems to be crucial for IL-1β processing (20, 22, 52, 53). CTX blocks K+ efflux through Ca2+-activated K+ channels, whereas high K+-containing extracellular solution inhibits K+ efflux by reducing the K+ gradient between extracellular solution and intracellular milieu. However, LPC-induced K+ efflux was not markedly affected by CTX (T. Schilling and C. Eder, unpublished observations), suggesting voltage dependence of microglial IL-1β release. To clarify further whether the CTX-induced inhibition of LPC-stimulated IL-1β release is due to membrane depolarization, effects of CTX on LPC-stimulated IL-1β release were studied in the presence of the electroneutral K+ ionophore nigericin. Under these conditions, cells were depolarized by CTX, whereas the large K+ gradient between intracellular and extracellular solutions remained, so that nigericin induced K+ efflux. Our observation that nigericin was unable to reverse the inhibitory effect of CTX on LPC-stimulated IL-1β release demonstrates that membrane depolarization is the crucial factor reducing IL-1β secretion from LPC-stimulated microglial cells. Additional experiments are required to identify the exact mechanism by which membrane depolarization inhibits IL-1β secretion from microglial cells. The CTX-induced inhibition of IL-1β release cannot simply be explained by a depolarization-induced reduction of the driving force for Ca2+ entry through nonselective cation channels. LPC-induced intracellular Ca2+ increases were not markedly reduced in the presence of CTX (T. Schilling and C. Eder, unpublished observations).

Microglial Ca2+-activated K+ channels are encoded by the gene KCa3.1 (IKCa1 or KCNN4) (43). It has been demonstrated that selective blockade of KCa3.1 Ca2+-activated K+ channels attenuates acute brain damage caused by traumatic brain injury (54) and ameliorates the outcome of experimental autoimmune encephalomyelitis (55, 56). In experimental autoimmune encephalomyelitis mice, reduced IL-1β levels were detected following K+ channel inhibition (56), which could be related to inhibition of microglial activation in vivo.

LPC-induced IL-1β release and LPC-induced deramification are mediated by different physiological mechanisms

In microglia, LPC-induced release of IL-1β is accompanied by changes in cell morphology (32). Although both IL-1β release and deramification of microglial cells occur simultaneously after stimulation with LPC, both processes are mediated by different physiological mechanisms. First, IL-1β release strongly depends on Ca2+-influx through nonselective cation channels, whereas microglial shape changes are Ca2+-independent. Second, membrane hyperpolarization induced by functional Ca2+-activated K+ channels is required for IL-1β release, whereas the transformation of microglia from ramified into ameboid morphology is unaffected upon inhibition of Ca2+-activated K+ channels. Third, KCl efflux mediated by the activity of K+/Cl− cotransporters supports the retraction of cell extensions during microglial deramification, whereas K+/Cl− cotransporter activity is not required for the LPC-induced IL-1β release.

We suggest a model of LPC-induced IL-1β release (Fig. 10⇓). Similar to ATP, LPC stimulates rapid processing and release of IL-1β from LPS-preactivated microglia. However, neither ATP receptors nor ATP receptor-coupled channels are affected by LPC. LPC activates nonselective cation channels. The Ca2+ influx through nonselective cation channels causes substantial increases in the intracellular Ca2+ concentration, which subsequently lead to the activation of Ca2+-dependent K+ channels. The activity of Ca2+-activated K+ channels results in sustained membrane hyperpolarization. Both intracellular Ca2+ elevation and membrane hyperpolarization are required for optimal release of the processed, biologically active 17-kDa IL-1β into the extracellular milieu.

FIGURE 10.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 10.

Schematic model of IL-1β release from LPC-stimulated microglia. This model summarizes data of the present study. Details of the processes are described in Discussion.

Disclosures

The authors have no financial conflict of interest.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) Grant SFB 507/C7 (to C.E.) and Grant Schw 407/9-2 (to A.S.). C.E. is a recipient of a Heisenberg Fellowship.

  • ↵2 C.S. and T.S. contributed equally to this work.

  • ↵3 Address correspondence and reprint requests to Dr. Claudia Eder, Institute of Physiology, Medical Faculty Charité, Tucholskystrasse 2, D-10117 Berlin, Germany. E-mail address: claudia.eder{at}charite.de

  • ↵4 Abbreviations used in this paper: LPC, lysophosphatidylcholine; CTX, charybdotoxin; ICE, IL-1-converting enzyme; MTX, margatoxin; oATP, oxidized ATP; [Ca2+]i, intracellular Ca2+ concentration.

  • Received April 10, 2006.
  • Accepted October 4, 2006.
  • Copyright © 2006 by The American Association of Immunologists

References

  1. ↵
    Dinarello, C. A.. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Perry, V. H., T. A. Newman, C. Cunningham. 2003. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 4: 103-112.
    OpenUrlCrossRefPubMed
  3. ↵
    Allan, S. M., P. J. Tyrrell, N. J. Rothwell. 2005. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5: 629-640.
    OpenUrlCrossRefPubMed
  4. ↵
    Minami, M., Y. Kuraishi, K. Yabuuchi, A. Yamazaki, M. Satoh. 1992. Induction of interleukin-1β mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58: 390-392.
    OpenUrlCrossRefPubMed
  5. ↵
    Vezzani, A., M. Conti, A. De Luigi, T. Ravizza, D. Moneta, F. Marchesi, M. G. De Simoni. 1999. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19: 5054-5065.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Woodroofe, M. N., G. S. Sarna, M. Wadhwa, G. M. Hayes, A. J. Loughlin, A. Tinker, M. L. Cuzner. 1991. Detection of interleukin-1 and interleukin-6 in adult rat brain, following injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33: 227-236.
    OpenUrlCrossRefPubMed
  7. ↵
    Giulian, D., T. J. Baker, L. C. Shih, L. B. Lachman. 1986. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Quan, N., M. Whiteside, M. Herkenham. 1998. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83: 281-293.
    OpenUrlCrossRefPubMed
  9. ↵
    Hauser, S. L., T. H. Doolittle, R. Lincoln, R. H. Brown, C. A. Dinarello. 1990. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735-1739.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Martin, D., S. L. Near. 1995. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61: 241-245.
    OpenUrlCrossRefPubMed
  11. ↵
    Merrill, J. E., Y. Koyanagi, J. Zack, L. Thomas, F. Martin, I. S. Chen. 1992. Induction of interleukin-1 and tumor necrosis factor α in brain cultures by human immunodeficiency virus type 1. J. Virol. 66: 2217-2225.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    González-Scarano, F., J. Martín-García. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5: 69-81.
    OpenUrlCrossRefPubMed
  13. ↵
    Griffin, W. S., L. C. Stanley, C. Ling, L. White, V. MacLeod, L. J. Perrot, C. L. White, C. Araoz. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86: 7611-7615.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Yamasaki, Y., N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama, K. Kogure. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26: 676-680.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Stroemer, R. P., N. J. Rothwell. 1998. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat. J. Cereb. Blood Flow Metab. 18: 833-839.
    OpenUrlCrossRefPubMed
  16. ↵
    Relton, J. K., N. J. Rothwell. 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29: 243-246.
    OpenUrlCrossRefPubMed
  17. ↵
    Sherwin, C., R. Fern. 2005. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-α, IL-1β, and calcium. J. Immunol. 175: 155-161.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Cunningham, C., D. C. Wilcockson, S. Campion, K. Lunnon, V. H. Perry. 2005. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25: 9275-9284.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Yao, J., J. E. Keri, R. E. Taffs, C. A. Colton. 1992. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591: 88-93.
    OpenUrlCrossRefPubMed
  20. ↵
    Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, F. Di Virgilio. 1997. Purinergic modulation of interleukin-1 from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Ferrari, D., M. Villalba, P. Chiozzi, S. Falzoni, P. Ricciardi-Castagnoli, F. Di Virgilio. 1996. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156: 1531-1539.
    OpenUrlAbstract
  22. ↵
    Sanz, J. M., F. Di Virgilio. 2000. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J. Immunol. 164: 4893-4898.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Bianco, F., E. Pravettoni, A. Colombo, U. Schenk, T. Möller, M. Matteoli, C. Verderio. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia. J. Immunol. 174: 7268-7277.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Chakfe, Y., R. Seguin, J. P. Antel, C. Morissette, D. Malo, D. Henderson, P. Seguela. 2002. ADP and AMP induce interleukin-1β release from microglial cells through activation of ATP-primed P2X7 receptor channels. J. Neurosci. 22: 3061-3069.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Ferrari, D., C. Pizzirani, E. Adinolfi, R. M. Lemoli, A. Curti, M. Idzko, E. Panther, F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176: 3877-3883.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Sun, G. Y., F. F. Foudin. 1984. On the status of lysolecithin in rat cerebral cortex during ischemia. J. Neurochem. 43: 1081-1086.
    OpenUrlCrossRefPubMed
  27. ↵
    Kinouchi, H., S. Imaizumi, T. Yoshimoto, H. Yamamoto, M. Motomiya. 1990. Changes of polyphosphoinositides, lysophospholipid, and free fatty acids in transient cerebral ischemia of rat brain. Mol. Chem. Neuropathol. 12: 215-228.
    OpenUrlCrossRefPubMed
  28. ↵
    Yegin, A., S. H. Akbas, T. Ozben, D. K. Korgun. 2002. Secretory phospholipase A2 and phospholipids in neural membranes in an experimental epilepsy model. Acta Neurol. Scand. 106: 258-262.
    OpenUrlCrossRefPubMed
  29. ↵
    Kabarowski, J. H., Y. Xu, O. N. Witte. 2002. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 64: 161-167.
    OpenUrlCrossRefPubMed
  30. ↵
    Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730.
    OpenUrlCrossRefPubMed
  31. ↵
    Ousman, S. S., S. David. 2000. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30: 92-104.
    OpenUrlCrossRefPubMed
  32. ↵
    Schilling, T., F. Lehmann, B. Rückert, C. Eder. 2004. Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J. Physiol. 557: 105-120.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Raivich, G., M. Bohatschek, C. U. Kloss, A. Werner, L. L. Jones, G. W. Kreutzberg. 1999. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev. 30: 77-105.
    OpenUrlPubMed
  34. ↵
    Streit, W. J., S. A. Walter, N. A. Pennell. 1999. Reactive microgliosis. Prog. Neurobiol. 57: 563-581.
    OpenUrlCrossRefPubMed
  35. ↵
    Colomar, A., V. Marty, C. Medina, C. Combe, P. Parnet, T. Amedee. 2003. Maturation and release of interleukin-1β by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors. J. Biol. Chem. 278: 30732-30740.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Schilling, T., C. Stock, A. Schwab, C. Eder. 2004. Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration. Eur. J. Neurosci. 19: 1469-1474.
    OpenUrlCrossRefPubMed
  37. ↵
    Grynkiewicz, G., M. Poenie, R. Y. Tsien. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Perregaux, D. G., C. A. Gabel. 1998. Human monocyte stimulus-coupled IL-1β posttranslational processing: modulation via monovalent cations. Am. J. Physiol. 275: C1538-C1547.
    OpenUrlPubMed
  39. ↵
    Liu-Wu, Y., E. Hurt-Camejo, O. Wiklund. 1998. Lysophosphatidylcholine induces the production of IL-1β by human monocytes. Atherosclerosis 137: 351-357.
    OpenUrlCrossRefPubMed
  40. ↵
    Kim, S. H., C. J. Smith, L. J. Van Eldik. 2004. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol. Aging 25: 431-439.
    OpenUrlCrossRefPubMed
  41. ↵
    Eder, C.. 1998. Ion channels in microglia (brain macrophages). Am. J. Physiol. 275: C327-C342.
    OpenUrlPubMed
  42. ↵
    Eder, C., R. Klee, U. Heinemann. 1997. Pharmacological properties of Ca2+-activated K+ currents of ramified murine brain macrophages. Naunyn Schmiedebergs Arch Pharmacol. 356: 233-239.
    OpenUrlCrossRefPubMed
  43. ↵
    Schilling, T., H. Repp, H. Richter, A. Koschinski, U. Heinemann, F. Dreyer, C. Eder. 2002. Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca2+-dependent K+ channels. Neuroscience 109: 827-835.
    OpenUrlCrossRefPubMed
  44. ↵
    Yao, J., R. W. Johnson. 1997. Induction of interleukin-1β-converting enzyme (ICE) in murine microglia by lipopolysaccharide. Brain Res. Mol. Brain Res. 51: 170-178.
    OpenUrlCrossRefPubMed
  45. ↵
    Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing monocytes. Nature 356: 768-774.
    OpenUrlCrossRefPubMed
  46. ↵
    Murgia, M., S. Hanau, P. Pizzo, M. Rippa, F. Di Virgilio. 1993. Oxidized ATP: an irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268: 8199-8203.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    MacKenzie, A., H. L. Wilson, E. Kiss-Toth, S. K. Dower, R. A. North, A. Surprenant. 2001. Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 15: 825-835.
    OpenUrlCrossRefPubMed
  48. ↵
    Gudipaty, L., J. Munetz, P. A. Verhoef, G. R. Dubyak. 2003. Essential role for Ca2+ in regulation of IL-1β secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am. J. Physiol. 285: C286-C299.
    OpenUrlCrossRef
  49. ↵
    Brough, D., R. A. Le Feuvre, R. D. Wheeler, N. Solovyova, S. Hilfiker, N. J. Rothwell, A. Verkhratsky. 2003. Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1β and IL-1α from murine macrophages. J. Immunol. 170: 3029-3036.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Yun, M. R., F. Okajima, D. S. Im. 2004. The action mode of lysophosphatidylcholine in human monocytes. J. Pharmacol. Sci. 94: 45-50.
    OpenUrlCrossRefPubMed
  51. ↵
    Mackenzie, A. B., H. Chirakkal, R. A. North. 2003. Kv1.3 potassium channels in human alveolar macrophages. Am. J. Physiol. 285: L862-L868.
    OpenUrlCrossRef
  52. ↵
    Perregaux, D., C. A. Gabel. 1994. Interleukin-1β maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269: 15195-15203.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Walev, I., K. Reske, M. Palmer, A. Valeva, S. Bhakdi. 1995. Potassium-inhibited processing of IL-1β in human monocytes. EMBO J. 14: 1607-1614.
    OpenUrlPubMed
  54. ↵
    Mauler, F., V. Hinz, E. Horvath, J. Schuhmacher, H. A. Hofmann, S. Wirtz, M. G. Hahn, K. Urbahns. 2004. Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma. Eur. J. Neurosci. 20: 1761-1768.
    OpenUrlCrossRefPubMed
  55. ↵
    Beeton, C., H. Wulff, J. Barbaria, O. Clot-Faybesse, M. Pennington, D. Bernard, M. D. Cahalan, K. G. Chandy, E. Béraud. 2001. Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 98: 13942-13947.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Reich, E. P., L. Cui, L. Yang, C. Pugliese-Sivo, A. Golovko, M. Petro, G. Vassileva, I. Chu, A. A. Nomeir, L. K. Zhang, et al 2005. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. 35: 1027-1036.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 177 (12)
The Journal of Immunology
Vol. 177, Issue 12
15 Dec 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lysophosphatidylcholine Stimulates IL-1β Release from Microglia via a P2X7 Receptor-Independent Mechanism
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lysophosphatidylcholine Stimulates IL-1β Release from Microglia via a P2X7 Receptor-Independent Mechanism
Christian Stock, Tom Schilling, Albrecht Schwab, Claudia Eder
The Journal of Immunology December 15, 2006, 177 (12) 8560-8568; DOI: 10.4049/jimmunol.177.12.8560

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lysophosphatidylcholine Stimulates IL-1β Release from Microglia via a P2X7 Receptor-Independent Mechanism
Christian Stock, Tom Schilling, Albrecht Schwab, Claudia Eder
The Journal of Immunology December 15, 2006, 177 (12) 8560-8568; DOI: 10.4049/jimmunol.177.12.8560
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606